Chairman and CEO Khurram Sheikh will host the live call on Wednesday, November 4, 2026 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time; investors may register now and submit questions through the ...
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces that Myriad management will participate in three upcoming healthcare conferences.
Tech stocks are bouncing back Monday after last week's selloff, which was fueled by growing investor concerns over massive AI infrastructure spending. Several big-name tech stocks are sitting out the ...
Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven ...
The Recapitalization eliminates approximately $96 million of annual cash interest on the Senior Notes Substantial new capital and liquidity: $400 million of new money through a rights offering of new ...
STEINHAUSEN, Switzerland, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Transocean Ltd. (NYSE: RIG) today issued a quarterly Fleet Status Report that provides the current activity and contractual status of the ...
USA Rare Earth, Inc. (Nasdaq: USAR) (the Company), today announced that it will release financial results for the quarterly period ended September 30, 2026, after U.S. markets close on Monday, ...
Special meeting of Impact Biomedical stockholders to approve the proposed Business Combination scheduled for November 13, 2026, at 10:00 a.m. Eastern Standard Time Upon closing, the combined company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results